ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

PRME Prime Medicine Inc

5.59
0.00 (0.00%)
プレマーケット
最終更新日: 17:00:00
15分遅延
名称 銘柄コード 市場 種別
Prime Medicine Inc PRME NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 5.59 17:00:00
始値 安値 高値 終値 前日終値
5.59
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0121:00GLOBEPrime Medicine to Participate in the 27th Annual Milken..
2024/4/2920:00GLOBEPrime Medicine Announces FDA Clearance of Investigational..
2024/4/2321:00GLOBEPrime Medicine to Present Preclinical Data Demonstrating..
2024/3/0122:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0122:04EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0122:01EDGAR2Form 8-K - Current report
2024/3/0122:00GLOBEPrime Medicine Reports Full Year 2023 Financial Results and..
2024/2/2822:00GLOBEPrime Medicine to Participate in Upcoming Investor..
2024/2/2407:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2407:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2311:31EDGAR2Form SC 13D - General statement of acquisition of beneficial..
2024/2/2107:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2106:01GLOBEPrime Medicine Announces Closing of Upsized Public Offering..
2024/2/1620:23EDGAR2Form 8-K - Current report
2024/2/1620:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/1513:50GLOBEPrime Medicine Announces Pricing of Upsized Public Offering
2024/2/1511:57EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
2024/2/1507:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/1506:12EDGAR2Form 8-K - Current report
2024/2/1506:05GLOBEPrime Medicine Announces Proposed Public Offering of Common..
2024/1/2522:00GLOBEPrime Medicine Receives Up to $15 Million from Cystic..
2024/1/0822:01EDGAR2Form 8-K - Current report
2024/1/0607:03EDGAR2Form 8-K - Current report
2024/1/0522:15EDGAR2Form 8-K - Current report
2024/1/0522:00GLOBEPrime Medicine Appoints Allan Reine, M.D., as Chief..
2024/1/0222:00GLOBEPrime Medicine to Present at 42nd Annual J.P. Morgan..
2023/11/1414:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/11/0822:00GLOBEPrime Medicine to Present at Upcoming Investor Conferences
2023/11/0406:23EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/0406:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0405:06EDGAR2Form 8-K - Current report
2023/11/0405:01GLOBEPrime Medicine Reports Third Quarter 2023 Financial Results..
2023/10/2719:00GLOBEPrime Medicine Presents First-ever Prime Editing Data in..
2023/10/2420:30GLOBEPrime Medicine Presents First In Vivo Proof-of-Concept Prime..
2023/10/1721:00GLOBEPrime Medicine to Highlight Positive Preclinical..
2023/9/1921:00GLOBEPrime Medicine to Present at Upcoming Investor Conferences
2023/8/3121:00GLOBEPrime Medicine to Present at Upcoming Investor Conferences
2023/8/0805:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0805:04EDGAR2Form 8-K - Current report
2023/8/0805:01GLOBEPrime Medicine Reports Second Quarter 2023 Financial Results..
2023/6/2221:00GLOBEPrime Medicine and Cimeio Therapeutics Announce Research..
2023/5/3121:00GLOBEPrime Medicine to Present at Investor Conferences in June
2023/5/1805:05GLOBEPrime Medicine to Present at Virtual Investor Conferences in..
2023/5/1719:00GLOBEPrime Medicine to Present New Preclinical Data Highlighting..
2023/5/1121:00GLOBEPrime Medicine Reports First Quarter 2023 Financial Results..

最近閲覧した銘柄

Delayed Upgrade Clock